Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
"how come you know how MED3000 works and nobody else does? You said, "The Dermasys mode of action... is based on evaporation..." "
===============================================================================
Bucolic, becasue I am the 'Eagle'flying high!! I can see things that others may miss.
No seriously, you should know this. Dermasys was the long standing 'base' technology upon which all FUM applications were built...it (the name) is trademarked...but not patented. Dermasys in the FUM literature (paraphrasing somewhat) was described as the transport of the active ingredient via the suitable selection of base solvents through the skin membrane using evaporation to create a superconcentration of the active molecule, forcing it through the skin.
MED3000 is 'obviously' different because there is 'apparently' no active ingredient....it works (according to the 'theory') in a totally new way (some cooling/heating cycle). So in that respect MED3000 and Dermasys have parted company....or so the 'theory' goes!!
Personally I believe it's 'tinkerbell' dust...
Baldy, how come you know how MED3000 works and nobody else does? You said, "The Dermasys mode of action... is based on evaporation..." I believe that was a suggestion of how it might work, yet you're presenting it as fact.
"Baldy, you said that having a patent on the oil in a car, but not on the car itself might be a bad idea, "
=============================================================================
Bucolic, I don't believe I said that...patent on the formulation would be OK, patent(s) on the vehicle would be better.
People are always amazed that Dermasys isn't patented. The patents are on the 'formulations' for each application. The Dermasys mode of action itself isn't patented...because as theItalian alluded to it is based on evaporation, which is a natural phenomenon & therefore 'probably' cannot be patented.
But MED3000 is different...the mode of action was unexpected and could open up the possibility for patents on Dermasys itself. Which would be the holy grail. But first they need to investigate why MED3000 actually works. But if nobody but me is interested...then that makes me happy!
I still have my elephant to go hunting.
"How about telling us about the elephant in the room that you keep alluding to?"
====================================================================
Bucolic, people weren't really interested. It's a theory I have but hasn't been investigated propely. Not a fact, so I cannot promote my theory without substance...it wouldn't be appropriate.
i really think this is a complete non issue. personally i do not think it is possible to patent the method of action as such, as that is a physical process, as opposed to the formulation or the process steps involved in producing the physical response. imo this is a complete and pointless distraction from any serious issues of substance, with which investors other should be concerning themselves.other opinions are,i fear,available.
But there were patents on paracetamol initially. It was sold in the US from 1950 to 1959 as RX only, and in '59 became OTC. Baldy, you said that having a patent on the oil in a car, but not on the car itself might be a bad idea, but if you have the patent on something that is essential for other things that work around it, then you're in control, as far as I can see. I think you need to start beating a different drum. How about telling us about the elephant in the room that you keep alluding to?
Paracetamol works....we know it works, it is cheap and effective. The NHS gives it for everything, like sweeties!!
I presume they have theories on how it works but nobody is going to pay to investigate. It is cheap & widely available. There is very little point in trying to enhance something that works effectively & cheaply. There wouldn't be much point in getting patents on something sold so cheaply.
MED3000 is different. They might be able to get IP on what they find. It also might lead to methods for enhancing the actual product.
Also a competitor might do the investigation instead and find something that they can patent, leaving FUM with a patent on the 'formulation' of MED3000 but the competitor with the patent on how it works....I suspect one is more valuable than the other in terms of IP. Like having a patent on the oil in the car but not the patent(s) for the car.
But if you guys & gals are 'happy' with that possible scenario then that's OK too.
No scaremongering intended on my part....just stating a fact and highlighted two benefits of understanding the mode of action.
If FUM aren't attempting to understand better how MED3000 actually works then that could be a mistake (but I am sure they are). Knowing how MED3000 works could lead to an enhanced product and also additional IP....both very worthwhile aims. But I suppose we may have to make do with Ken's theory.
You would be surprised, so many drugs that are prescribed have partially unknown mechanisms. In this "festive" area of male aches remedies we have Minoxidil, it makes your hair grow but actually science was blurry for years. Viagra was found by mistake, topiramate makes you thin although it is meant as an anti-epileptic medicine. I could carry on but we all get the point
All those were safe to use and have ended up totally or partially being used for a different condition
good find ndr50. of course it was never going to be a problem. just scaremongering and negative promotion I'm afraid.
Wow! They don't even know how paracetamol works! I don't think FUM have much to worry about with MED3000 then!
"Despite its common use, the mechanism of action of paracetamol is not completely understood." (wiki)
Source somewhat obvious but this gives you idea BE of just how many drugs used in medical profession with completely unknown mechanism. Medical devices tend to have their mechanisms more clearly defined. I agree it would be better if FUM could work out the mechanism but I don't think it will pose a problem if they can't in bringing this product to marketplace imo. Hopefully they will gather additional trial data to back up their claims and this will give ED sufferers confidence in the product. Then you can book your cruise and make your way to the fanatasy island that has become a reality.
https://en.wikipedia.org/wiki/Category:Drugs_with_unknown_mechanisms_of_action